Please login to the form below

Not currently logged in
Email:
Password:

MSD appoints new UK head

Mike Nally moves from Swedish division
MSD MIke Nally

Merck Sharp and Dohme (MSD) has announced that Mike Nally is to take on the role of managing director of the company's operations in the UK and Ireland.

Nally will take over the role on January 1, 2014, moving from his current position as managing director of MSD in Sweden.

He replaces Deepak Khanna who has been appointed to a new senior VP role at MSD where he will lead the company's oncology efforts across Europe.

As previously announced, Khanna will also step down from his role as president of the Association of the British Pharmaceutical Industry (ABPI) to be replaced by Pfizer's Jonathan Emms.

Commenting on Nally's work in Sweden, MSD said that “he has led the company to become a more customer centric organisation in a dynamic, payer-based environment”.

10th December 2013

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
fox&cat

up to your ears in it? some pressure is helpful but too much of the wrong sort quickly takes its...

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....